Although the evidence on tolerability and efficacy of this combination in childhood is lacking, it can be considered in selected cases, if the compliance to treatment is low and the hazard of TB is high.
A very high safety ratio and an absence of interaction with other mechanisms involved in blood pressure regulation, together with initial evidence of high tolerability and efficacy in hypertensive patients, indicate Rostafuroxin as the first example of a new class of antihypertensive agents designed to antagonize adducin and EO-hypertensive mechanisms.
This result confirms previous reports [ 14, 21] suggesting that one benefit of CBZ include the low propensity toward weight gain and evidence of good tolerability with long-term treatment.
Clinical studies have provided clear biomarker evidence of target engagement, tolerability, and therapeutic potential, especially activity in specific genotypes of breast and lung cancer, relating to tumor dependence on specific HSP90 clients.
Studies of rituximab in children with conditions such as chronic autoimmune cytopenias, however, have provided preliminary evidence of safety and tolerability in children [ 34, 35].
On the other side, evidence of higher gastrointestinal tolerability from RCTs is only available for rofecoxib, but this drug has been withdrawn from the market worldwide on September 2004 for evidence of increasing cardiovascular risk.
A phase I trial of volasertib in combination with cisplatin or carboplatin is currently ongoing and has demonstrated preliminary evidence of efficacy and tolerability in patients with advanced solid tumours (Deleporte et al, 2011) and a phase I trial of volasertib in combination with afatinib, an irreversible ErbB-family blocker, is currently ongoing.
The study provides evidence of the safety and tolerability of MSP3-LSP when given to young children with prior exposure to malaria in Burkina Faso.
These results provide ample evidence of the efficacy and tolerability of XP in Japanese patients.
Depot antipsychotics are often initiated in patients who have shown evidence of poor adherence or tolerability to oral medications [ 5].
